FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/19/2023
Back to search
Official data from USPTO
PROSTASPY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
06/19/2023
Trademark type
Combined
Nice classes
5
Filing date
06/16/2021
Registration date
01/24/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/24/2023
Last transaction
01/24/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
16
Owner location
DE
Examiner
CARR,PATRICK C
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "PROSTASPY" to the right of a design consisting of a shaded circle containing an off-center circle and around which are four partial circles.
Holders and representatives
Holders
ABX advanced biochemical compounds - Biomedizinische Forschungsreagenzien GmbH
Representatives
Philip C. Schroeder Buchalter
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medical and veterinary preparations for the diagnosis of diseases of the prostate; medical and veterinary preparations for the treatment of diseases of the prostate; medical and veterinary preparations for the diagnosis of cancer; medical and veterinary preparations for the treatment of cancer; dietetic foods and beverages for medical or veterinary purposes; nutritional supplements for humans and animals; nutritional supplements for the diagnosis of diseases of the prostate; nutritional supplements for the treatment of diseases of the prostate; nutritional supplements for the diagnosis of cancer; nutritional supplements for treating cancer; chemical preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate; chemical preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate; chemical preparations for medical or pharmaceutical purposes for the diagnosis of cancer; chemical preparations for medical or pharmaceutical purposes for the treatment of cancer; biological preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate; biological preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate; biological preparations for medical or pharmaceutical purposes for the diagnosis of cancer; biological preparations for medical or pharmaceutical purposes for the treatment of cancer; preparations for use in medical diagnostic processes; preparations for use in medical diagnostic processes relating to the diagnosis of diseases of the prostate; preparations for use in medical diagnostic processes relating to the diagnosis of cancer
Publications
History of USPTO decisions and trademark events.
26 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
05/02/2023
XXCR
GENERIC MADRID TRANSACTION CREATED
05/02/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/24/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/24/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
01/24/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/08/2022
PUBO
PUBLISHED FOR OPPOSITION
11/08/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/19/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/04/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/06/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/05/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/05/2022
RFNT
REFUSAL PROCESSED BY IB
05/25/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/04/2022
RFRR
REFUSAL PROCESSED BY MPU
05/04/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/23/2022
CNRT
NON-FINAL ACTION WRITTEN
03/22/2022
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
03/16/2022
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
03/16/2022
DOCK
ASSIGNED TO EXAMINER
03/08/2022
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
02/13/2022
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
01/28/2022
MAFR
APPLICATION FILING RECEIPT MAILED
11/09/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/05/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/28/2021
Continuous trademark protection
Get notified about every new filing that threatens PROSTASPY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.